AGP Executive Report
Last update: 12 hours agoFDA AI Sandbox: The UK’s MHRA opened a London “sandbox” to test AI medical devices in real NHS settings, aiming to answer safety, effectiveness, and data-governance questions that lab work can’t settle. Cardiac AI Approval: Caristo Diagnostics won US FDA De Novo authorization for CaRi-Heart, quantifying coronary inflammation from routine coronary CT angiography to flag earlier risk. Biopharma Strategy: Abzena’s exec advice for emerging biotechs: pick the endgame (partner, acquire, or launch), stress-test plans with CDMOs/CROs early, and avoid cheap shortcuts that create costly rewrites. India Pharma Regulation: India’s commerce minister Piyush Goyal pushed global cooperation among drug regulators to speed access to affordable, high-quality medicines. Medtech Market Push: South Africa’s WHX returns to Johannesburg as global medtech firms compete for a fast-growing R18.4bn device market. Healthcare Business Growth: Elevance Health CEO Gail Boudreaux’s career arc highlights how leadership talent can rise inside big health insurers. Funding & Ingredients: Arboreal Bioinnovations raised Rs 230 crore to scale functional ingredient tech for food and nutraceuticals. Early-Life Nutrition: A UK study links lower sugar intake in the first two years with lower later dementia risk, while experts stress it’s association, not proof.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
